Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions
Proceedings of the National Academy of Sciences · 18.06.2024 · 121 (25)
DOI: 10.1073/pnas.2322689121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.06.2024. Verfasst von Siham Zentout und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Rennes, CNRS, Institut de génétique et développement de Rennes-UMR 6290, Biologie, Santé, Innovation Technologique (BIOSIT)-UMS3480, Re…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Poly (ADP-Ribose) Polymerase-1, ADP-Ribosylation, Histones. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ligue Contre le Cancer (French League Against Cancer), Agence Nationale de la Recherche (ANR), Fondation ARC pour la Recherche sur le Cancer (ARC).
Abstract (Originalsprache)
Poly(ADP-ribose) polymerase 1 (PARP1) has emerged as a central target for cancer therapies due to the ability of PARP inhibitors to specifically kill tumors deficient for DNA repair by homologous recombination. Upon DNA damage, PARP1 quickly binds to DNA breaks and triggers ADP-ribosylation signaling. ADP-ribosylation is important for the recruitment of various factors to sites of damage, as well as for the timely dissociation of PARP1 from DNA breaks. Indeed, PARP1 becomes trapped at DNA breaks in the presence of PARP inhibitors, a mechanism underlying the cytotoxitiy of these inhibitors. Therefore, any cellular process influencing trapping is thought to impact PARP inhibitor efficiency, potentially leading to acquired resistance in patients treated with these drugs. There are numerous ADP-ribosylation targets after DNA damage, including PARP1 itself as well as histones. While recent findings reported that the automodification of PARP1 promotes its release from the DNA lesions, the potential impact of other ADP-ribosylated proteins on this process remains unknown. Here, we demonstrate that histone ADP-ribosylation is also crucial for the timely dissipation of PARP1 from the lesions, thus contributing to cellular resistance to PARP inhibitors. Considering the crosstalk between ADP-ribosylation and other histone marks, our findings open interesting perspectives for the development of more efficient PARP inhibitor-driven cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Rennes, CNRS, Institut de génétique et développement de Rennes-UMR 6290, Biologie, Santé, Innovation Technologique (BIOSIT)-UMS3480, Rennes F-35000, France.
- Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
ORCID-Profile: Victor Imburchia, Catherine Chapuis, Lena Duma, Ivan Ahel, Sébastien Huet
Förderung
- Ligue Contre le Cancer (French League Against Cancer)
- Agence Nationale de la Recherche (ANR)
- Fondation ARC pour la Recherche sur le Cancer (ARC)
- Wellcome Trust
- UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
- Institut National Du Cancer (INCa)
- Cancer Research United Kingdom
- Ovarian Cancer Research Alliance (OCRA)
Zitieren
APA
Zentout, S., Imburchia, V., Chapuis, C., Duma, L., Schützenhofer, K., Prokhorova, E., Ahel, I., Smith, R., & Huet, S. (2024). Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions. Proceedings of the National Academy of Sciences, 121(25). https://doi.org/10.1073/pnas.2322689121
Vancouver
Zentout S, Imburchia V, Chapuis C, Duma L, Schützenhofer K, Prokhorova E, et al. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions. Proceedings of the National Academy of Sciences. 2024;121(25). doi:10.1073/pnas.2322689121
BibTeX
@article{Zentout2024,
author = {Zentout, Siham and Imburchia, Victor and Chapuis, Catherine and Duma, Lena and Schützenhofer, Kira and Prokhorova, Evgeniia and Ahel, Ivan and Smith, Rebecca and Huet, Sébastien},
title = {Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {25},
doi = {10.1073/pnas.2322689121}
}
EUVIMED